Farnesytransferase inhibitor as neoadjuvant and adjuvant therapy in hamster pancreatic cancer model: is it effective?

Farnesytransferase inhibitor as neoadjuvant and adjuvant therapy in hamster pancreatic cancer model: is it effective? (2004)

Authors:
USP affiliated authors: BACCHELLA, TELESFORO - FM ; MACHADO, MARCEL CERQUEIRA CESAR - FM
Unidades: FM; FM
Subjects: NEOPLASIAS PANCREÁTICAS (CIRURGIA); CO-TERAPIA; HAMSTERS; ADENOCARCINOMA; RESUMOS (EVENTOS)
Language: Inglês
Imprenta:
- Place of publication: San Francisco
- Date published: 2004
Source:
- Título do periódico: Anais
Conference title: Pancreatic Cancer2004: advances and challenges

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT

MORIOKA, Cintia; MACHADO, Marcel Cerqueira César; SAITO, Seiji; et al. Farnesytransferase inhibitor as neoadjuvant and adjuvant therapy in hamster pancreatic cancer model: is it effective? Anais.. San Francisco: [s.n.], 2004.
APA

Morioka, C., Machado, M. C. C., Saito, S., Matheus, A. S., Ohzawa, K., Jukemura, J., et al. (2004). Farnesytransferase inhibitor as neoadjuvant and adjuvant therapy in hamster pancreatic cancer model: is it effective? In Anais. San Francisco.
NLM

Morioka C, Machado MCC, Saito S, Matheus AS, Ohzawa K, Jukemura J, Bacchella T, Arai H, Sakamoto T, Watanabe A. Farnesytransferase inhibitor as neoadjuvant and adjuvant therapy in hamster pancreatic cancer model: is it effective? Anais. 2004 ;
Vancouver

Morioka C, Machado MCC, Saito S, Matheus AS, Ohzawa K, Jukemura J, Bacchella T, Arai H, Sakamoto T, Watanabe A. Farnesytransferase inhibitor as neoadjuvant and adjuvant therapy in hamster pancreatic cancer model: is it effective? Anais. 2004 ;